The microsolvated
state of a molecule, represented by its interactions
with only a small number of solvent molecules, can play a key role
in determining the observable bulk properties of the molecule. This
is especially true in cases where strong local hydrogen bonding exists
between the molecule and the solvent. One method that can probe the
microsolvated states of charged molecules is differential mobility
spectrometry (DMS), which rapidly interrogates an ion’s transitions
between a solvated and desolvated state in the gas phase (i.e., few
solvent molecules present). However, can the results of DMS analyses
of a class of molecules reveal information about the bulk physicochemical
properties of those species? Our findings presented here show that
DMS behaviors correlate strongly with the measured solution phase
pKa and pKb values, and cell permeabilities of a set of structurally related
drug molecules, even yielding high-resolution discrimination between
isomeric forms of these drugs. This is due to DMS’s ability to separate species based upon only subtle (yet
predictable) changes in structure: the same subtle changes that can
influence isomers’ different bulk properties. Using 2-methylquinolin-8-ol
as the core structure, we demonstrate how DMS shows promise for rapidly
and sensitively probing the physicochemical properties of molecules,
with particular attention paid to drug candidates at the early stage
of drug development. This study serves as a foundation upon which
future drug molecules of different structural classes could be examined.